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for fatty acid regulation of virulence genes
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Cholera is an acute intestinal infection caused by the bacterium
Vibrio cholerae. In order for V. cholerae to cause disease, it must
produce two virulence factors, the toxin-coregulated pilus (TCP)
and cholera toxin (CT), whose expression is controlled by a tran-
scriptional cascade culminating with the expression of the AraC-
family regulator, ToxT. We have solved the 1.9 Å resolution crystal
structure of ToxT, which reveals folds in the N- and C-terminal
domains that share a number of features in common with AraC,
MarA, and Rob as well as the unexpected presence of a buried 16-
carbon fatty acid, cis-palmitoleate. The finding that cis-palmitoleic
acid reduces TCP and CT expression in V. cholerae and prevents
ToxT from binding to DNA in vitro provides a direct link between
the host environment of V. cholerae and regulation of virulence
gene expression.
AraC ∣ crystal structure ∣ pathogenesis ∣ oleic acid ∣ palmitoleic acid
Vibrio cholerae is a Gram-negative bacterium and the causativeagent of the acute intestinal infection known as cholera.
Upon entry into the host intestine, V. cholerae induces a transcrip-
tional cascade resulting in the expression of the master virulence
regulator, ToxT. ToxT directly activates the expression of the two
primary virulence factors of V. cholerae, the toxin-coregulated pi-
lus (TCP) and cholera toxin (CT) (1–3) and also autoregulates its
own expression from the tcp promoter (4, 5). ToxT is a member of
the AraC-family of transcriptional regulators which are defined
by a 100 amino acid region of sequence similarity that forms an
independently folding DNA-binding domain (DBD) containing
two helix-turn-helix (HTH) motifs (6). Members fall into three
functional groups depending on the types of genes that they reg-
ulate. Those members that regulate carbon metabolism, such as
AraC of E. coli, are active as dimers and respond to small effector
molecules that bind to the N-terminal domain of the protein.
Those members that are involved in the stress response, such as
SoxS, Rob, and MarA typically function as monomers. The third
group is involved in regulating virulence gene expression and in-
cludes Rns of enterotoxigenic E. coli (7), BfpT (PerA) of enter-
opathogenic E. coli (8), and ExsA of Pseudomonas aeruginosa (9),
amongst numerous others. These regulators may respond to
physical cues such as temperature and pH and it is not yet known
if they function primarily as monomers or dimers. To date, of
the large number of known AraC-family proteins (PROSITE,
PS01124 (6)), only two full-length structures, MarA (10) and
Rob (11), have been solved.
ToxT activates the transcription of many promoters, includ-
ing those that control the tcp and ctx operons, via binding to de-
generate thirteen base-pair sequences called toxboxes. These se-
quences are organized either singly, or in direct or inverted repeat
configurations (12) such that ToxT can function at promoters to
positively regulate gene transcription as either a monomer or a
dimer depending on the structure of the promoter (13, 14). The
activity of ToxT is known to be sensitive to bile, a mixture of many
molecules including saturated fatty acids (SFAs), unsaturated
fatty acids (UFAs), salts, and cholesterol that is secreted into
the intestine from the gall bladder (15, 16). In the presence of
bile, and more specifically bile components oleic, linoleic acid,
or arachidonic acid, transcription of ctxA and tcpA by V. cholerae
is drastically reduced, leading to the suggestion that ToxT func-
tion is inhibited by UFAs found in bile (16).
In this study, the full-length structure of ToxT is determined
and shown to be similar in overall structure with the regulator
AraC. Unexpectedly, the structure revealed the regulatory do-
main of ToxTwas bound to a ligand, the sixteen-carbon fatty acid
cis-palmitoleate. The addition of cis-palmitoleate to V. cholerae
culture media reduced ctx and tcp expression by 6–8 fold similar
to what was previously observed with oleic acid (16) and both
UFAs prevented the sequence specific DNA-binding of ToxT
in vitro. These results suggest a model in which the presence
of UFAs reduce virulence gene expression by directly binding
to ToxT and altering the conformation of the protein such that
it is less competent to bind to DNA and less likely to form
stable dimers.
Results and Discussion
Structure of Full-Length ToxT and Comparison with Other AraC-family
Members.We have solved the 1.9 Å resolution crystal structure of
ToxT (Fig. 1A, Table S1, PDB ID 3GBG). The crystal contained
one monomer of ToxT per asymmetric unit, with each monomer
containing two domains. The N-terminal domain (amino acids 1–
160) is comprised of three α-helices (helix α1–α3) and a nine
stranded β-sandwich (strand β1–β9) forming a “jelly roll” or “cu-
pin-like” fold (17) containing a binding pocket enclosed by resi-
dues Y12, Y20, F22, L25, I27, K31, F33, L61, F69, L71, V81, and
V83 from the N-terminal domain and residues I226, K230, M259,
V261, Y266, and M269 from the C-terminal domain (Fig. S1).
The volume of this predominantly hydrophobic pocket is
780.9 Å3 as calculated by the program CASTp (18). The pocket
contains a sixteen-carbon fatty acid bound such that its negatively
charged carboxylate head group forms salt bridges with both K31
from the N-terminal domain and K230 from the C-terminal do-
main (Fig. 1B; see discussion below). Following a short linker
(amino acids 161–169), the C-terminal domain (170–276) is made
up of two HTH DNA-binding motifs (the more N-terminal
HTH1 and the more C-terminal HTH2) linked by a relatively
long α-helix, helix α7. The interface between the two domains
has an area of ∼2000 Å2 and is very polar, with few hydrophobic
interactions (Fig. S2).
Structures of other AraC-family members are limited to three
members: AraC, in which the N- (19) and C-terminal (20) domain
structures have been determined separately (Fig. 2), MarA, which
contains only a DNA-binding domain (10), and Rob, which, in
contrast to ToxTand AraC, contains an N-terminal DNA-binding
domain and a C-terminal regulatory domain (11). Both the MarA
and Rob structures have been cocrystallized with DNA. The
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C-terminal domain of Rob, like the N-terminal domains of ToxT
and AraC, is composed of several helices and β-sheets forming a
binding pocket. While the structure of Rob contains no ligand,
the N-terminal domain of AraC (PDB ID 2ARC) has been de-
termined with arabinose bound in the β-sandwich in a position
similar to the fatty acid in ToxT (Fig. 2).
A comparison of full-length ToxTwith existing high resolution
structures using Distance ALIgnment (DALI) (21) and Second-
ary Structure Matching (SSM) (22) gave no significantly similar
hits over the entire 276 amino acids. However, when the
two domains are taken separately, the N-terminal domain of
ToxT most closely resembles the N-terminal domain of AraC
(for 126 α-carbons, the RMSD is 3.63 Å; PDB ID 1XJA (23)),
while the C-terminal domain is most similar to the DBD of AraC
(RMSD 2.12 Å for 92 α-carbons; PDB ID 2K9S (20)). ToxTand
AraC have a very similar N-terminal topology (Fig. S3A) and
other than the N-terminal arm of AraC (residues 7–17), all of
the other secondary structural elements of these two proteins can
be aligned (Fig. S3B).
N-Terminal Domain. The fold of the N-terminal domain of ToxT is
similar to AraC in that it contains eight antiparallel β-sheets
(Fig. 1A) followed by helix α1 (19). However, ToxT is missing
the N-terminal arm that is present in AraC that interacts with
arabinose. Helix α1 and sheet β9 are linked by a disordered region
between residues 101 and 110. Childers et al. have shown that
alanine substitutions of four of these residues (M103, R105,
N106, and L107) show either greatly enhanced ctxAp-lacZ expres-
sion or≤10% expression of the ctxAp-lacZ and acfA-phoA fusions
(24) demonstrating this region is important for virulence gene ex-
pression. Helix α3 of ToxT is analogous to the helix that allows for
coiled-coil N-terminal dimerization in the AraC structure (19).
Although ToxT is clearly a monomer in this structure and appears
to bind to independent toxboxes as a monomer (13), certain pro-
moters such as tcp, ctx, and tagA require ToxT dimerization on
adjacent toxboxes for full activation (13, 14). In AraC, the coiled-
coil is anchored at the ends by a triad of leucine residues provid-
ing stability (19). Although analogous leucine residues are not
present in α3, if ToxT were to dimerize in a manner similar to
that observed in AraC, complementary salt bridges would be
formed between helix α3 residues such as D141, E142, K157,
and K158 of one monomer and the same residues on the other
monomer. In fact, Hsaio et al. have suggested that a D141G sub-
stitution is able to repress msh promoters as a monomer, but is
unable to activate tcp (25).
A number of residues in the N-terminal domain have been
shown to be important for ToxT mediated activation of virulence
gene expression (24). As suggested by Childers et al., those in-
volved in maintaining an N-terminal hydrophobic core (M32,
W34, I35, L42, L60, L71, W117, L127, F147–148, and F151–
152) are essential for protein folding and stability (24). Two sur-
face exposed glutamates, E52 in β5, and E129 in α2, as well as
S140, which lies in the loop between α2 and α3, have also been
shown important for function (24) for reasons not illuminated by
the structure.
Hung et al. have identified a small molecule inhibitor of ToxT,
virstatin (26), that interferes with its ability to dimerize and acti-
vate transcription of the tcp and ctx promoters (14). They also
demonstrated that a L114P substitution is virstatin resistant
and suggested that it may favor a conformation that allows the
protein to dimerize more efficiently (14). It is interesting to note
that L114 lies in the vicinity of the unresolved residues (residues
101 and 110) (Fig. 1A) and substitution to a proline may result in
Fig. 1. The structure of ToxT. (A) Ribbon diagram of ToxT showing α-helices
(gold), β-strands (cyan), and loops (dark red). The bound cis-palmitoleate is
shown in stick form with carbons in green and oxygens in red. The N and
C termini are indicated. Helices and strands are numbered according to their
topological connectivity in the full-length protein. Note that residues 101–
110 are disordered in the structure, as indicated by the loop ends on the left
side of the molecule. (B) Close up of the cis-palmitoleate binding region
showing interactions of the carboxylate head group with side chains.
Fig. 2. Ribbon diagrams of ToxTand the N- and C-terminal domains of AraC.
The models are colored by a rainbow effect with blue at the N terminus and
red at the C terminus. The arabinose bound in the N-terminal domain of AraC
is shown in stick form. PDB accession numbers are indicated for the three
structures.
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a conformational change affecting the adjacent unresolved loop
or N-terminal ligand binding pocket.
DNA-Binding Domain. The DBD of ToxT is composed of seven α-
helices. HTH1 is comprised of α5 and α6, HTH2 is comprised of
α8 and α9, and they are connected by a central helix α7 (Fig. 1A).
Helix α4 and helix α10 are involved in scaffolding and stability of
HTH1 and HTH2 respectively. Pairwise SSM alignments per-
formed by WinCoot (27, 28) of the DBD’s of ToxT (amino acids
170–273), AraC, andMarA, show consistently close alignments of
HTH2, with greater variability in the orientation of HTH1
(Fig. 3). The DNA-bound structure of MarA demonstrates that
it is possible for AraC-family members to utilize helices α6 and
α9, oriented in a parallel manner, to bind consecutive major
grooves on curved target DNA (10). This parallel arrangement
is conserved in Rob; however the structure does not show both
HTH motifs bound to major grooves (11). As suggested by Rod-
gers and Schleif (20), helix α6 of AraC, which is at a divergent
angle with respect to helix α9, would likely have to undergo a con-
formational change in order to allow for consecutive major
groove binding on target DNA. In ToxT, helix α6 is not only non-
parallel with helix α9, but is also more distorted and bent when
compared to what is observed in AraC (Fig. 3). Another differ-
ence in this domain is in the orientation of helix α7. In AraC and
MarA, the orientation of helix α7 is virtually the same, whereas in
ToxT helix α7 is orientated differently with respect to the other
structures. As discussed below, the position of helix α7 is such that
it could link the N-terminal binding pocket to conformational
changes occurring in the DNA-binding domain.
Residues identified by Childers et al. in the C-terminal domain
that are important for ToxT function include several in the cores
of HTH1 and HTH2 (I174, V178, W186, W188, L206, V211,
I217, F245, F251, and F255) (24) that are critical for proper fold-
ing and stability. There are also a number of surface exposed re-
sidues that could be involved in stabilizing the DBD (S175, R184,
R221, S227, E233, K237, G244, and N260) (24). Finally, it ap-
pears that residues such as K203 (α6), R214 (α7), T253 (α9),
and S257 (α9) are positioned to be directly involved in pro-
tein/DNA interactions.
A Fatty Acid is Present in ToxT and Influences its DNA-binding Activity.
UFAs such as arachidonic, linoleic, and oleic acid have previously
been shown to strongly inhibit the expression of ToxT-activated
genes, whereas SFAs such as palmitic and stearic acid do not
(16). The structure of ToxTcontains an almost completely buried
and solvent inaccessible sixteen-carbon fatty acid bound to
the pocket in the N-terminal domain (Fig. 1A and B, Fig. 2,
Fig. S1A and B). The negative charge on the carboxylate head
group hydrogen bonds with Y12 and forms salt bridges with
K31 from the N-terminal domain and K230 from the C-terminal
domain (Fig. 1B, Fig. S1D). NMR studies of chloroform/metha-
nol extractions from pure ToxTsamples indicate the presence of a
long-chain, singly unsaturated fatty acid in a cis configuration
(Fig. S4). Although the electron density ends after carbon sixteen
of the hydrophobic chain, suggesting cis-palmitoleate, the ToxT
structure could accommodate the two additional carbons of ole-
ate (Fig. S1C). An Fo-Fc difference map calculated after refine-
ment with oleate placed into the pocket shows strong negative
density after carbon sixteen, further indicating that the bound
molecule is cis-palmitoleate.
To address whether cis-palmitoleate was capable of influencing
the activity of ToxT, different UFAs and SFAs were added to cul-
tures of V. cholerae strains carrying transcriptional fusions to the
tcp and ctx operons. We found that the expression of these oper-
ons were reduced between 6–8 fold with cis-palmitoleic acid and
between 10–15 fold with oleic acid, whereas only a twofold reduc-
tion was observed with palmitic acid (Fig. 4A and B). As previous
studies have shown that toxT transcription is unaffected by UFAs,
it has been suggested that UFAs act on ToxT directly (16).
EMSAs were performed, and a 100-fold molar excess of pro-
tein was shown to bind to a 40 base-pair probe containing two
toxboxes from the tcp promoter in vitro (Fig. 4C, lane 2). This
interaction is specific since it was completely inhibited by a 70-
fold molar excess of specific competitor DNA (lane 3) but not
Fig. 3. Pairwise SSM alignments of the DBDs of ToxT (3GBG), AraC (2K9S),
andMarA (1BL0). ToxT is represented in silver, AraC in blue, and MarA in dark
red. Helix α7 and the DNA-binding helices α6 and α9 are labeled. Arrows in-
dicate the relative direction each DNA-binding helix is pointing. The asterisk
indicates the distorted section of helix α6 on ToxT.
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by a 70-fold molar excess of nonspecific competitor DNA (lane
4). Addition of methanol or 0.002% palmitic acid to the reaction
had no effect on ToxT binding (Fig. 4D, lanes 5 and 6). However,
addition of 0.002% palmitoleic or oleic acid completely pre-
vented ToxT from binding to DNA (Fig. 4D, lanes 7 and 8), con-
sistent with the reduction of tcp and ctx transcription observed in
the presence of these fatty acids (Fig. 4A and B). A control EMSA
experiment with a different protein/DNA pair was also per-
formed to show that unsaturated fatty acids do not block all
protein/DNA interactions (Fig. S5).
As no fatty acids were added to any buffer or crystalli-
zation condition, the cis-palmitoleate most likely originated from
the E. coli used as the protein expression strain. Indeed, cis-
palmitoleic acid comprises 10.5% of the total fatty acid content
in E. coli membranes, whereas oleic acid is absent (29). As it is
expected that there would be very little free fatty acid in the
cytoplasm of these bacteria, it is likely that ToxT bound cis-
palmitoleate released from the membrane upon cell lysis. Other
groups have seen similar phenomena such as the binding of cis-
vaccenic acid by the pheromone-binding protein of Bombyx mori
when purified from an E. coli expression system (29). Previous
studies indicate that 23.5% of the fatty acid content of bile is oleic
acid, and if cis-palmitoleic acid is present in bile, it is at a con-
centration of less than 0.5%. As both oleic and cis-palmitoleic
acids are monounsaturated at the ninth carbon and as there is
room in the ToxT structure to potentially accommodate the long-
er oleic acid, it is not surprising that both fatty acids can serve as a
ligand for ToxT. However, given the abundance of oleic acid in
bile when compared to cis-palmitoleic acid, it seems that oleic
acid would be the natural ligand responsible for altering ToxT
function in vivo.
A Structural Model for ToxT Activation. The finding that UFAs re-
duce the expression of tcp and ctx expression in V. cholerae and
that they significantly reduce the ability of ToxT to bind to DNA
in vitro suggests a model for the regulation of ToxT function via
fatty acid binding (Fig. 5). In this model, when the bacteria are in
the lumen of the intestine in the presence of fatty acids, the posi-
tion of the carboxylate head group of the fatty acid bridging K31
from the N-terminal domain with K230 from the C-terminal do-
main (Fig. 1B) keeps ToxT in a “closed” conformation that is not
capable of binding DNA (5). Restraint of K230, which is located
at the C-terminal end of helix α7, would cause helix α7 to assume
a position that pulls and distorts helix α6 into an orientation that
is unfavorable for DNA-binding (Fig. 3). Once the bacteria have
penetrated the mucus of the intestine where the concentrations of
fatty acids are presumably reduced (15), charge-charge repulsion
between K31 and K230 destabilizes the closed conformation,
leading to an opening of the N- and C-terminal domains. In this
“open” conformation, K230, helix α7, and helix α6 would no long-
er be restrained, and reorient into a conformation that is compe-
tent for DNA-binding. The EMSA data support this model, in
which an equilibrium exists between fatty acid bound “closed”
ToxT that cannot bind to DNA and fatty acid free “open” ToxT
that can bind to DNA. While a 50-fold molar excess of ToxTover
the probe is not sufficient to drive the binding equilibrium in the
direction of the DNA-bound state (Fig. 4D, lane 2), increasing
the concentration of ToxT (Fig. 4D, lanes 3 and 4) shifts the equi-
librium in the direction of a protein/DNA complex. Addition of
0.002% palmitoleic or oleic acid then disrupts the protein/DNA
complex by shifting the equilibrium back to the “closed” state,
containing a protein/fatty acid complex, releasing it from DNA
(Fig. 4D, lanes 7 and 8). As discussed above, a number of studies
have suggested that ToxT dimerizes upon binding to adjacent tox-
boxes (12, 14, 26, 30). It is clear from the structure that side-by-
side dimerization of “closed” ToxTon adjacent toxboxes would be
Fig. 4. Effects of fatty acids on tcp and ctx expression. (A) and (B) β-galac-
tosidase activity of tcp-lacZ and ctx-lacZ fusion constructs respectively. Cells
were grown in LB pH 6.5 at 30 °C for 18 hoursþ∕− the indicated fatty acids at
0.02% dissolved in methanol. The inset shows TcpA expression by Western
blot under the same conditions in the corresponding lanes (C—control with
methanol; PA—sodium palmitate; POA—palmitoleic acid; OA—oleic acid). (C)
EMSA showing a specific interaction between ToxT and a 40-base-pair seg-
ment of the tcp promoter. All lanes contain 0.0025 μM labeled probe. Lane
1, free DNA; lane 2, 0.2 μM ToxT; lane 3, 0.2 μM ToxT with a 70-fold molar
excess of cold competing DNA; lane 4, 0.2 μMToxTwith a 70-fold molar excess
of a 42-base-pair nonspecific DNA cold competitor. (D) EMSA showing the
effect of several fatty acids on ToxT/DNA interactions. All lanes contain
0.0025 μM labeled probe. Lane 1, free DNA; lane 2, 0.125 μM ToxT; lane 3,
0.2 μM ToxT; lane 4, 0.25 μM ToxT; lane 5, 0.25 μM ToxT with methanol; lane
6, 0.25 μM ToxTwith 0.002% palmitic acid; lane 7, 0.25 μM ToxTwith 0.002%
palmitoleic acid; lane 8, 0.25 μM ToxT with 0.002% oleic acid.
Fig. 5. Model for the regulation of ToxT by monounsaturated fatty acids.
Fatty acid bound ToxT is in a “closed” conformation, which cannot bind
to DNA. Release of the fatty acid results in an “open” conformation that
can bind to DNA. In the “open” conformation the N-terminal domain is free
to move in relation to the C-terminal domain, and is able to dimerize with
another ToxT at an adjacent toxbox. The linker is sufficiently flexible to allow
dimerization on DNA in either direct or inverted orientations.
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difficult if not impossible due to steric constraints. However,
we predict the “open” form of ToxT would be able to dimerize
on adjacent toxboxes in either the direct or inverted orientations
(Fig. 5).
These studies describe the high resolution structure of ToxT
and provide evidence that UFAs decrease the ability of ToxT
to interact with DNA. The presence of a UFA in ToxT provides
a direct link between the host environment of V. cholerae and the
regulation of virulence gene expression. Further insights into the
mechanisms by which UFAs influence ToxTwill contribute to our
understanding of this critical regulatory step in the disease pro-
cess. In addition, this structure provides a foundation for studying
the mechanisms by which small molecules such as virstatin (14,
26) are able to inhibit ToxT function as well as the therapeutic
potential of UFAs in the treatment of cholera.
Materials and Methods
ToxT Expression. ToxTwas purified using the IMPACT-CN fusion protein system
(New England Biolabs). Full-length ToxT was cloned from Vibrio cholerae
O395 and ligated into pTXB1 (New England Biolabs) to produce a toxT-
intein/CBD (chitin binding domain) fusion construct. ToxT was expressed
by autoinduction (31) in ZYM-5052 media using BL21-CodonPlus® (DE3)-
RIL (Stratagene) E. coli. All Luria-Burtani broth (LB) agar plates and media
contained 100 μgmL−1 carbenicillin and 25 μgmL−1 chloramphenicol. Sele-
nomethionine ToxT was produced by growing the same E. coli strain in a
minimal medium phosphate amino acids selenomethionine (PASM-5052)
containing a mixture of 10 μgmL−1 methionine, 125 μgmL−1 selenomethio-
nine, and 100 nanomolar (nM) vitamin B12.
Purification of ToxT. Cells were harvested by centrifugation, resuspended in
column buffer (20 mM Tris pH 8.0, 1 mM EDTA, and 500 mM NaCl), lysed
via French press, and clarified by centrifugation. Chitin beads (New England
Biolabs) were equilibrated with cold column buffer, mixed with the clarified
supernatant, and incubated at 4 °C with gentle rocking. The chitin bead slurry
was then loaded onto a gravity flow column, washed with 10 column
volumes of column buffer, and equilibrated with five column volumes of
cleavage buffer (20 mM Tris pH 8.0, 1 mM EDTA, and 150 mM NaCl). The in-
tein with the CBD was cleaved from ToxTusing cleavage buffer with 100 mM
dithiothreitol (DTT) and left at 4 °C for 20 h. Eluant from the chitin column
was then loaded onto a HiTrap sepharose packed (SP) fast flow (FF) cationic
exchange column (GE) to separate the ToxT-intein/CBD fusion protein that
coeluted with the native ToxT using a sodium chloride gradient. Pure frac-
tions were pooled and concentrated to 1.75 mgmL−1 for crystallization.
Crystallization of ToxT. ToxT was crystallized in hanging drops where 50% of
the drop was ToxT in buffer from the cationic exchange column, 30% of the
drop was 0.1 M Hepes pH 7.5 with 10% ðw∕vÞ PEG 8,000 (the mother liquor),
and 20% of the drop was 36–40% 2-methyl-2,4-pentandiol (MPD) as an ad-
ditive. ToxT crystals were transferred to a solution containing the mother li-
quor and 20% ethylene glycol as a cryoprotectant.
X-ray Data Collection. A multiple anomalous dispersion (MAD) dataset from
selenomethionine ToxT was collected on X6A in the National Synchotron
Light Source at the Brookhaven National Laboratory, Long Island NY. A high
resolution native data was collected on GM/CA-CAT in the Advanced Light
Source at Argonne National Laboratory, Argonne IL. Data were indexed with
X-ray Detector Software (XDS) (32), solved by Solve/Resolve (33, 34), refined
with the Crystallography and NMR System (CNS) (35, 36), and the model was
built using WinCoot (27, 28). A Ramachandran plot generated with Procheck
(37, 38) shows 99.6% of residues in the most favored or additionally allowed
regions and no residues in the disallowed regions.
Fatty Acid Extractions. Fatty acids were extracted from samples of aqueous
ToxT by the method of Bligh and Dyer (39). Samples were resuspended in
methanol-d4 and used for NMR spectra. Positive controls of sodium palmitate
(Sigma, P9767) and cis-palmitoleic acid (Fluka, 76169) were also dissolved in
methanol-d4.
NMR Experiments. All NMR experiments were acquired on a Bruker spectro-
meter operating at 600 MHz, utilizing a TCI cryoprobe. All data were col-
lected at 25 °C. Spectral assignment utilized chemical shift comparison with
values reported in the literature for fatty acids (40) and reference spectra
obtained for samples of sodium palmitate and palmitoleic acid in the same
experimental conditions. The assignment was confirmed by two dimensional
homonuclear NMR experiments Total Correlation Spectroscopy (TOCSY) (41),
mixing times of 60 and 120 ms, and Nuclear Overhauser Enhancement Spec-
troscopy (NOESY) (42), mixing time of 200 ms), and heteronuclear 1H-13C
HMQC (43) and HMBC (44) experiments.
Electrophoretic Mobility Shift Assays. Single-stranded, forty base-pair compli-
mentary oligos (Operon) from the tcp promoter (5′GTGTTATTAAAAAAA-
TAAAAAAACACAGCAAAAAATGACA) were end labeled with a biotin-
conjugated dUTP using the Biotin 3′ End Labeling Kit (Pierce) following
the manufacturer’s instructions and then annealed to form double-stranded
fragments. EMSA’s were carried out using the LightShift Chemilumi-
nescent EMSA Kit (Pierce) following the manufacturer’s instructions. Briefly,
2.5 picomole (pmole), 4 pmole, 5 pmole of ToxT were mixed with 50 femto-
mole (fmole) of double-stranded labeled DNA in a binding buffer (10 mM Tris
pH 7.5, 1 mM EDTA, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.3 mgmL−1 BSA,
150 μg herring sperm DNA, and 10% glycerol). Fatty acids were dissolved in
methanol and added to a final concentration of 0.002% using the same vo-
lume of methanol as a control. To show specificity, a 70-fold molar excess of
unlabeled double-stranded tcp fragment and a 70-fold molar excess of un-
labeled nonspecific DNA (42 base pairs) were added as controls. Reactions
were then incubated for 30 min at 30 °C and loaded on a 1x Tris Borate EDTA
(TBE ) 6% polyacrylamide gel at 4 °C then transferred onto a positively
charged membrane (Hybond XL, GE Healthcare) and detected by chemilumi-
nescence. An EMSA experiment was conducted using the control reagents
from the LightShift Chemiluminescent EMSA Kit following the manufac-
turer’s instructions while adding methanol and 0.02% fatty acids as indicated
in Fig. S5.
β-galactosidase Assays. β-galactosidase activity was determined by the meth-
od of Miller (45). The tcp-lacZ and ctx-lacZ strains MBN135 (46) and KSK218
(47) were grown for 18 h in LB media pH 6.5 at 30 °C. Either methanol or the
indicated fatty acids were added to 0.02%.
Immunoblot Analysis. Cell extracts from 18 h cultures grown as for the β-
galactosidase assays were prepared and analyzed on 16% SDS-polyacryla-
mide slab gels. Proteins were visualized by transferring to nitrocellulose
and probing with antiTcpA antibody (48) using the enhanced chemilumines-
cence (ECL) detection system (Amersham).
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